CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for MediRox AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

MediRox AB
Studsvik
Phone: +46 15522194646p:+46 15522194646 Nykoping, 61199  Sweden Fax: +46 155263011f:+46 155263011
Business Summary
MediRox AB is a Sweden-based medical technology company. It is mainly engaged in the area of diagnosis of cardiovascular diseases. The Company’s products utilize the FOR (Free Oscillation Rheometry) technology, which is a sensitive blood viscosity measuring method. Its products are divided into two product areas, namely Reagents and controls, for coagulation assays in routine diagnostics, and ReoRox, which determines blood and plasma viscosity, elasticity and coagulation. The Company's customers include medical laboratories, animal hospitals, intensive care wards and pharmaceutical companies. The Company primarily sells its products on the Nordic market, as well as in other parts of Europe and the world. As of 12/23/2016, MediRox AB is majority owned by Ahead Global Investment Ltd.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201612/31/2016Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3826 Laboratory analytical instruments

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board PeterSchmid 59 4/21/2016 8/12/2014
Member of the Management Board, Chief Executive Officer RobertLofvenmark 44 5/3/2012 1/1/2004
Finance Director, Member of the Management Board AnnaGimlander 4/1/2014 4/1/2014
6 additional Officers and Directors records available in full report.

Business Names
Business Name
MediRox AB
MROX A
MROX B

General Information
Number of Employees: 15 (As of 12/31/2016)
Outstanding Shares: 5,934,000 (As of 12/31/2016)
Shareholders: 562
Stock Exchange: STO
Fax Number: +46 155263011


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, July 23, 2023